FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201860892> ?p ?o ?g. }

• W3201860892 abstract "Aim: This research aimed to investigate the neurotoxicity of low-dose cyclophosphamide (CYP) on the urinary bladder of rats by in vivo and in vitro studies. Methods: To establish CYP-induced cystitis rat model, rats were treated with three intraperitoneal injections of CYP (25 mg/kg) in a week. During treatment, the up-down method was used to assess the mechanical withdrawal threshold. On day 8, urodynamic test and bladder smooth muscle contractility study, including the contraction of bladder strips to electrical field stimulation (EFS, 2-64 Hz), carbachol (CCh, 10-8-10-5 M) and KCl (120 mM), were performed to evaluate the function of bladder function. Body weight and bladder weight were also recorded. Morphometric analysis using an optical microscope and transmission electron microscope was performed to observe the changes of microstructure and submicrostructure of the bladder. The major pelvic neurons were isolated and treated with acrolein (the main CYP metabolite) to assess apoptosis in vitro. RT-PCR assays were used to quantify the mRNA expression levels of Nlrp6, Asc, Casp11 and Casp1 in bladder tissues and primary neurons. Results: After CYP injections, the body weights decreased, but the bladder weights increased in the model group. The mechanical withdrawal threshold of the cystitis model remained at a low level. The morphometric analysis suggested bladder inflammation and neuroinflammation in the bladder of the cystitis rat model. Urodynamic test revealed that, the amplitude, the pressure baseline, the peak pressure and pressure threshold of model rats significantly increased after CYP treatment. The muscle strips of model rats exhibited significantly higher contractility caused by EFS and CCh than the controls. Apoptotic cells appeared at the highest concentration group (100 μM acrolein) after 6 h of acrolein incubation in apoptosis assay of primary neurons. The mRNA expression levels of Nlrp6 and Casp11 were significantly increased in the cystitis rat model and in the acrolein-treated neurons. Conclusions: Low-dose CYP treatment was confirmed to induce nerve injury, which leading to bladder pain and overactive bladder in female rats, and the up-regulation of Nlrp6 and Casp11 may contribute to these pathological changes." @default.
• W3201860892 created "2021-10-11" @default.
• W3201860892 creator A5004018778 @default.
• W3201860892 creator A5005628887 @default.
• W3201860892 creator A5018465546 @default.
• W3201860892 creator A5024528227 @default.
• W3201860892 creator A5037706361 @default.
• W3201860892 creator A5037798401 @default.
• W3201860892 creator A5038995187 @default.
• W3201860892 creator A5050886789 @default.
• W3201860892 creator A5067636820 @default.
• W3201860892 creator A5077471473 @default.
• W3201860892 creator A5077703699 @default.
• W3201860892 creator A5080577523 @default.
• W3201860892 creator A5090897496 @default.
• W3201860892 date "2021-10-01" @default.
• W3201860892 modified "2023-10-12" @default.
• W3201860892 title "Low-Dose Cyclophosphamide Induces Nerve Injury and Functional Overactivity in the Urinary Bladder of Rats" @default.
• W3201860892 cites W1482787294 @default.
• W3201860892 cites W1561041814 @default.
• W3201860892 cites W1600358811 @default.
• W3201860892 cites W1974479037 @default.
• W3201860892 cites W1986225568 @default.
• W3201860892 cites W1998794592 @default.
• W3201860892 cites W2025477762 @default.
• W3201860892 cites W2058262412 @default.
• W3201860892 cites W2060674460 @default.
• W3201860892 cites W2075048079 @default.
• W3201860892 cites W2092747438 @default.
• W3201860892 cites W2092898101 @default.
• W3201860892 cites W2094069592 @default.
• W3201860892 cites W2099896731 @default.
• W3201860892 cites W2103329755 @default.
• W3201860892 cites W2167927725 @default.
• W3201860892 cites W2206611795 @default.
• W3201860892 cites W2217553469 @default.
• W3201860892 cites W2383935568 @default.
• W3201860892 cites W2476934550 @default.
• W3201860892 cites W2565573950 @default.
• W3201860892 cites W2593398334 @default.
• W3201860892 cites W2626489343 @default.
• W3201860892 cites W2763681094 @default.
• W3201860892 cites W2777187005 @default.
• W3201860892 cites W2790487160 @default.
• W3201860892 cites W2891935368 @default.
• W3201860892 cites W2899131445 @default.
• W3201860892 cites W2906572232 @default.
• W3201860892 cites W2909946224 @default.
• W3201860892 cites W2939911647 @default.
• W3201860892 cites W2973222161 @default.
• W3201860892 cites W2983989819 @default.
• W3201860892 cites W3000416397 @default.
• W3201860892 doi "https://doi.org/10.3389/fnins.2021.715492" @default.
• W3201860892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8517437" @default.
• W3201860892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34658764" @default.
• W3201860892 hasPublicationYear "2021" @default.
• W3201860892 type Work @default.
• W3201860892 sameAs 3201860892 @default.
• W3201860892 citedByCount "3" @default.
• W3201860892 countsByYear W32018608922023 @default.
• W3201860892 crossrefType "journal-article" @default.
• W3201860892 hasAuthorship W3201860892A5004018778 @default.
• W3201860892 hasAuthorship W3201860892A5005628887 @default.
• W3201860892 hasAuthorship W3201860892A5018465546 @default.
• W3201860892 hasAuthorship W3201860892A5024528227 @default.
• W3201860892 hasAuthorship W3201860892A5037706361 @default.
• W3201860892 hasAuthorship W3201860892A5037798401 @default.
• W3201860892 hasAuthorship W3201860892A5038995187 @default.
• W3201860892 hasAuthorship W3201860892A5050886789 @default.
• W3201860892 hasAuthorship W3201860892A5067636820 @default.
• W3201860892 hasAuthorship W3201860892A5077471473 @default.
• W3201860892 hasAuthorship W3201860892A5077703699 @default.
• W3201860892 hasAuthorship W3201860892A5080577523 @default.
• W3201860892 hasAuthorship W3201860892A5090897496 @default.
• W3201860892 hasBestOaLocation W32018608921 @default.
• W3201860892 hasConcept C120770815 @default.
• W3201860892 hasConcept C126322002 @default.
• W3201860892 hasConcept C126894567 @default.
• W3201860892 hasConcept C134018914 @default.
• W3201860892 hasConcept C150903083 @default.
• W3201860892 hasConcept C1918360 @default.
• W3201860892 hasConcept C207001950 @default.
• W3201860892 hasConcept C2776694085 @default.
• W3201860892 hasConcept C2776755627 @default.
• W3201860892 hasConcept C2779762690 @default.
• W3201860892 hasConcept C2780080261 @default.
• W3201860892 hasConcept C2780159080 @default.
• W3201860892 hasConcept C71924100 @default.
• W3201860892 hasConcept C86803240 @default.
• W3201860892 hasConceptScore W3201860892C120770815 @default.
• W3201860892 hasConceptScore W3201860892C126322002 @default.
• W3201860892 hasConceptScore W3201860892C126894567 @default.
• W3201860892 hasConceptScore W3201860892C134018914 @default.
• W3201860892 hasConceptScore W3201860892C150903083 @default.
• W3201860892 hasConceptScore W3201860892C1918360 @default.
• W3201860892 hasConceptScore W3201860892C207001950 @default.
• W3201860892 hasConceptScore W3201860892C2776694085 @default.
• W3201860892 hasConceptScore W3201860892C2776755627 @default.
• W3201860892 hasConceptScore W3201860892C2779762690 @default.
• W3201860892 hasConceptScore W3201860892C2780080261 @default.

• next